Member Info for itisagame

Need a 3rd group

Peptide

Placebo

Nothing

Maybe it’s so happened that the peptide and placebo group both increased the results Vs a nothing group baseline.

Look at the prior results, the difference between Bp-101 and placebo was basically double each number in the study.

It worked there, it works on rats, the peptide must make a difference, my guess is maybe they tried to low of dosing in latest study, or it was manufactured incorrectly and inactive / amino acids were broke down or something compared to initial

Or (by my basic google research) : Covid / Covid vaccines / boosters or something has effected absorption through Cribriform plate to brain, everyone would have been vaccinated and there’s many strange unknown unexpected things the mRNA jabs do. Auz and NZ were very forceful with uptake.

Https://ovocabio.com/app/uploads/2020/03/Ovoca-Bio-plc-Libicore-Presentation-2019.pdf

Ivix libicore

API substance - Switzerland

Final drug product - UK

So Made in Same countries as the Russian p1/2/3 trials.

Might be a silly question but… are they using the same manufacturers as last P3 trial

“The drug supplied for this study has been outsourced to well-established manufacturers in Switzerland and the UK.”

“Orenetide is a synthetic peptide administered through a nasal spray and has been supplied for this study by well-established peptide manufacturers in Switzerland and the UK.”

And they used varying dosages this time

“its Phase II dose ranging study assessing Orenetide conducted in Australia and New Zealand”

Last time “ Patients self-administered either 2.52 mg of Libicore (BP-101) or placebo on a daily basis using a nasal inhaler. “

Somethings off here and it’s bugging me.

Https://pubmed.ncbi.nlm.nih.gov/28189563/#:~:text=BP101%20Peptide%20Promotes%20Female%20Sexual%20Receptivity%20in%20the%20Rat.

Conclusion: BP101 displays a potent stimulatory effect on sexual motivation in the female rat, and the medial preoptic area seems to be the site of its action. BP101 is effective in female rats receiving different hormone supplementations, making the present data generalizable to pre- and postmenopausal women with hypoactive sexual desire. Andreev-Andrievskiy A, Lomonosov M, Popova A, et al. BP101 Peptide Promotes Female Sexual Receptivity in the Rat. J Sex Med 2017;14:336-346.

You can hear the tumbleweed whispering ….. …. £2mil cassssshhh …

Given the volume Friday the options are :

-Bond conversions

-an upsizing to the retail placing from 250k to £1-2m maybe more if so rns in morning will confirm.

If they are doing it properly then they need >£10m to level it out plus more for working capital as time goes by as their monthly spend is horrendous.

All rubbish technology, just use oil, it works great, there’s enough for hundreds of years which is long enough for the human race to be fighting wars with sticks and stones again.

Green trash is only getting pushed because certain groups want to con trillions of $ out of everyone else.

They are struggling to finance the business with the £3.75m of Arena bonds outstanding which can be converted at 5% discount to 3 day VWAP, if the new investor is not linked to Arena then the new investor has the potential to lose control before the second part of the raise, the mass of volume (and mass of volume next week) could also potentially be bond conversions selling off.

A very dirty set of accounts for a newly listed company which should have listed with enough capital to meet the target and with no legacy debt but they came to market with sunshine, rainbows, castle in the sky stories of potential grandeur with no way of financing it.

If the management had any idea how to run a listed company these capital requirements would have been met long ago with minimal disruption at >£1, unless ofcourse it has been a case of willful blindness in order to capitalise later on (or like the ex CFO pump - sell in to the highs, run) .

No one has been left behind anywhere the battery world is global and almost anything you want it available in 8-12 weeks

this company sucks because of its admin costs and licensing fees, the IPO was just a method of extracting cash while putting some towards development ready for the next owner to take to production for no cost or next to nothing once developed enough to get to production.

If it was designed to make shareholders money they would have settled licensing costs in shares at the start and not paid themselves as much until revenue was flowing.

Just looking at how they measured the outcome, and i see the "The Female Sexual Distress Scale-Revised (FSDS-R;revised 2005)" for another co (google) and "Female Sexual Function Index", its just a questionaire, a survey, nothing scientific measuring bloods levels / phyical changes (for the particular ones i saw on google anyway) so its all down to interpretation.

How many of these questions could have been answered technically incorrect because of a degree of embarrassment, prudishness, sensitivity, guilt, its not even a 1-10 or 1-100 score its 1-4, even if they said 2 at start then 3 after its a pointless scale of differential when so small

Probably got a more direct answer from Russians than the sensitive Auzzies and left leaning New Zealanders.

How often did you feel

1. Distressed about your sex life 0 1 2 3 4

2. Unhappy about your sexual relationship 0 1 2 3 4

3. Guilty about sexual difficulties 0 1 2 3 4

4. Frustrated by your sexual problems 0 1 2 3 4

5. Stressed about sex 0 1 2 3 4

6. Inferior because of sexual problems 0 1 2 3 4

7. Worried about sex 0 1 2 3 4

8. Sexually inadequate 0 1 2 3 4

9. Regrets about your sexuality 0 1 2 3 4

10. Embarrassed about sexual problems 0 1 2 3 4

11. Dissatisfied with your sex life 0 1 2 3 4

12. Angry about your sex life 0 1 2 3 4

13. Bothered by low sexual desire 0 1 2 3 4

Have fun answering them yourself based on how you feel now and before you invested here.

Avacta might end up being be a wonderful product but….

£300m mcap, £44M CLN, £40m cash last December so maybe what ~£20-25m cash currently?, monthly issuing of stock to pay bond interest

By default over time It’s going to get hammered in to the ground, might be great for bondholders who pick up cheap equity but the odds are less favourable for holders of existing equity, I’d say 85% chance of a 75%-90% drop there in a year or two when cash runs out and bonds outstanding, 10% chance sp ranges with a downward trend, 5% chance it rises and you get the moon shot RNS but even then for only 3x potential it’s currently priced on the high side, I’d was 5-10x potential.

I know it has its fan clubs but My gut says it inevitably runs out of money and equity screwed, but I do hope it does end favourably, or atleast a product they are involved in comes to market and actually helps people.

As for OVB - just test it again elsewhere, if it works great, it not move on.

Frustration is understandable, but the company itself is doing great really and much further along the path, in a much better position than the share price reflects, delays become great trading ops but dont really matter in long term.

Shares are for trading, not marrying but everyone has their own methods, trade your way up or wait either way it will 10 bag eventually but you got to be in it to win it.

Mazzzzzzzzuuuurrrrrggggghhhhhhh you happy ol soul 😜

The MO cash and loan is Likely being converted to stock to get Russell to that magic 30% isn’t it.

The 5/10p warrants were always going to be excised consodering share has been above that since trading resumed, but I expect that they were hoping for news and volume to churn them in to, but as today shows plenty of buyers but they are just waiting for the deal to come to them.

will all be resolved and running to your expected standard soon I expect, you can’t change the past but you can make a buck predicting the future ;)

Who knows, but I’d say maybe the 5/10p warrants prob being excised that were extended (extension period expiry not mentioned in March RNS)

Well I didn’t expect it but there’s your 18p mazza lol

I think 2018 - 2023 to get an asset, do all the paperwork, approvals, raising capital and listing a company, prepare the site for production, build needed infrastructure, build a team, actually start production, sales, design and implementation of an initial exploration campaign for cobalt, research potential additional licenses, while planing and working towards a future that eventually results in the sale of the company is pretty quick. (While having to deal With a bit of Covid / scamdemics / inflation / recession / supply shortages / general African and UK bureaucracy)

And all on a relatively small budget, with little dilution (will be ~100m in issue by end of it, not billions like many)

Compare to what, how long has cast been waiting for its diamonds? How long has iconic labs been raising capital to pay off egho? How long has trp been trying to get a drill going? And the many other examples in hundreds of companies while management take untold millions in salaries.

;) smiles all round

Millionaire or not dumping it all in the market that way was a stupid way to lose £125k more than he needed to.**

Millionaire or not throwing dumping it all in the market that was a stupid way to lose £125k more than he needed to.